Skip to main content

Study

Testosterone Therapy May Help Maintain Muscle in Older Men on Diabetes Medication

In men with low testosterone levels, hormone therapy might help preserve muscle mass when taking certain diabetes drugs.

Weight ManagementMuscle Health
Study Credibility: Low4.2/10Early findingsNot enough evidence yetTalk with your clinician
PublishedMar 2026JournalCureusDesignReviewLast reviewedApr 2026
Email this

Summary

In plain language

Recent research suggests that testosterone replacement therapy could be a helpful strategy for older men who have low testosterone levels and are taking GLP-1 receptor agonists, a common type of diabetes medication. This therapy might help preserve lean muscle mass, which tends to decrease as men age, especially when managing diabetes. Maintaining muscle is important for overall health and mobility. This finding is particularly relevant for seniors as it highlights a potential way to combat muscle loss, a common issue with aging. If you or a loved one are concerned about muscle loss while managing diabetes, this could be a worthwhile topic to discuss with your healthcare provider.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study reviewed existing research to understand how GLP-1 receptor agonists, a type of weight loss medication, affect muscle mass in men with low testosterone. Here's what they found:

  • GLP-1 medications can lead to substantial weight loss but also result in some muscle mass loss.

  • Men with low testosterone might experience more muscle loss, but testosterone therapy could help maintain muscle.

  • No direct studies have combined these treatments, so more research is needed.

It's important to talk to your healthcare provider about how these treatments might fit your health needs.

Research Quality Score

Scored April 28, 2026 using rubric v9_2026-04-08.

Assessment

The study is a structured narrative review examining the role of testosterone replacement therapy in preserving lean mass during GLP-1 receptor agonist-associated weight loss. While it provides a comprehensive synthesis of existing literature, it lacks a formal consensus methodology and evidence grading. The review is partially transparent with a structured search strategy but does not fully disclose the methodology. The journal is reputable but not top-tier, and the study's relevance to seniors is moderate due to its focus on testosterone and muscle health.

Category Breakdown

CategoryScoreRating
Consensus methodology3.3/10
Panel composition & bias5.0/10
Statistical methodsNot applicable to this type of study
Transparency & process5.0/10
Conflicts & funding5.0/10
Endorsement & adoption0.0/10
Relevance to chosen population5.0/10
Publishing body quality5.0/10

Additional Notes

The study provides valuable insights but should be interpreted with caution due to its narrative review nature and lack of formal consensus methodology.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.